| Entry |
|
|---|
| Name |
SARS-CoV-2 nsp3 to RIG-I-IRF7/3 signaling pathway
|
|---|
| Definition |
nsp3 -| ISG15 == IRF3 |
|---|
| Expanded |
K25013 -| 9636 == 3661 |
|---|
| Class |
|
|---|
| Type |
Pathogen
|
|---|
| Pathway |
|
|---|
| Disease |
|
|---|
| Gene |
| 9636 | ISG15; ISG15 ubiquitin like modifier |
| 3661 | IRF3; interferon regulatory factor 3 |
|
|---|
| Perturbant |
| K25013 (nsp3) | nsp3; SARS coronavirus non-structural protein 3 |
|
|---|
| Reference |
|
|---|
| Authors |
McClain CB, Vabret N |
|---|
| Title |
SARS-CoV-2: the many pros of targeting PLpro. |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Stancioiu F, Papadakis GZ, Kteniadakis S, Izotov BN, Coleman MD, Spandidos DA, Tsatsakis A |
|---|
| Title |
A dissection of SARSCoV2 with clinical implications (Review). |
|---|
| Journal |
|
|---|
| LinkDB |
|
|---|
